FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
+42%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$443M
AUM Growth
+$443M
(+116%)
Cap. Flow
+$187M
Cap. Flow
% of AUM
42.12%
Top 10 Holdings %
Top 10 Hldgs %
94.78%
Holding
19
New
7
Increased
1
Reduced
4
Closed
4
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
$91.1M |
| 2 |
Nurix Therapeutics
NRIX
|
$82M |
| 3 |
ALX Oncology
ALXO
|
$36.7M |
| 4 |
Arbutus Biopharma
ABUS
|
$10.4M |
| 5 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$5.03M |
Top Sells
| 1 |
Fulcrum Therapeutics
FULC
|
$20.7M |
| 2 |
Vaxcyte
PCVX
|
$7.65M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$7.65M |
| 4 |
Oric Pharmaceuticals
ORIC
|
$4.22M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$635K |
Sector Composition
| 1 | Healthcare | 99.59% |
